HIV and Tuberculosis : A Formidable Alliance / edited by Irini Sereti, Gregory P. Bisson, Graeme Meintjes
1. Overview of the HIV-associated tuberculosis epidemic -- 2 . Epidemiology of Drug-susceptible, Drug-resistant Tuberculosis and HIV in Africa -- 3. Modelling the HIV-associated TB epidemic and the impact of interventions aimed at epidemic control -- 4. Immune responses to Mycobacterium tuberculosis and the impact of HIV infection -- 5. Clinical Manifestations of HIV-associated tuberculosis in adults -- 6. The tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) -- 7. Diagnosis of HIV-associated tuberculosis -- 8. Recent advances in the treatment of latent tuberculosis infection among adults living with HIV -- 9. Treatment of drug-sensitive tuberculosis in persons with HIV -- 10. Drug-resistant TB and HIV -- 11. Co-treatment of tuberculosis and HIV: pharmacologic considerations -- 12. HIV and TB in children -- 13. Neurological TB in HIV.
Globally, HIV-associated tuberculosis is one of the most important causes of infection-related death, accounting for over 300,000 deaths worldwide in 2017. The HIV epidemic has undermined TB control efforts in many countries across the world, as the virus has important modifying effects on the pathogenesis, diagnosis, and treatment of TB. The management of HIV-associated TB is also complicated by rapid clinical progression, immune reconstitution inflammatory syndrome, drug-drug interactions, and shared toxicities. The past two decades have yielded thousands of research publications and review articles on HIV-associated TB. HIV and Tuberculosis: A Formidable Alliance consolidates this massive amount of data into a single resource. With contributions from myriad disciplines, including epidemiology, immunology, public health, and clinical medicine, this book provides well-rounded and thorough coverage that will appeal to researchers and clinicians alike.
| Medienart: |
E-Book |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
Cham: Springer ; 2019 |
| Ausgabe: |
1st ed. 2019 |
| Reihe: |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sereti, Irini [HerausgeberIn] |
|---|
| Links: |
|---|
| ISBN: |
|---|
| Nlm: |
WF 200 |
|---|---|
| Themen: |
AIDS-Related Opportunistic Infections |
| Umfang: |
1 Online-Ressource (X, 347 p. 32 illus., 23 illus. in color) |
|---|
| doi: |
10.1007/978-3-030-29108-2 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
1684967198 |
|---|
| LEADER | 01000cam a22002652 4500 | ||
|---|---|---|---|
| 001 | 1684967198 | ||
| 003 | DE-627 | ||
| 005 | 20230427200051.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191210s2019 gw |||||o 00| ||eng c | ||
| 020 | |a 9783030291082 |9 978-3-030-29108-2 | ||
| 024 | 7 | |a 10.1007/978-3-030-29108-2 |2 doi | |
| 035 | |a (DE-627)1684967198 | ||
| 035 | |a (DE-599)KEP048678295 | ||
| 035 | |a (DE-He213)978-3-030-29108-2 | ||
| 035 | |a (EBP)048678295 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 044 | |c XA-DE | ||
| 050 | 0 | |a QR355-502 | |
| 060 | 0 | |a WF 200 | |
| 072 | 7 | |a MKFM |2 thema | |
| 072 | 7 | |a MMFM |2 bicssc | |
| 072 | 7 | |a MED052000 |2 bisacsh | |
| 245 | 1 | 0 | |a HIV and Tuberculosis |b A Formidable Alliance |c edited by Irini Sereti, Gregory P. Bisson, Graeme Meintjes |
| 250 | |a 1st ed. 2019 | ||
| 264 | 1 | |a Cham |b Springer |c 2019 | |
| 300 | |a 1 Online-Ressource (X, 347 p. 32 illus., 23 illus. in color) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 490 | 0 | |a Springer eBooks |a Biomedical and Life Sciences | |
| 490 | 0 | |a Springer eBook Collection | |
| 520 | |a 1. Overview of the HIV-associated tuberculosis epidemic -- 2 . Epidemiology of Drug-susceptible, Drug-resistant Tuberculosis and HIV in Africa -- 3. Modelling the HIV-associated TB epidemic and the impact of interventions aimed at epidemic control -- 4. Immune responses to Mycobacterium tuberculosis and the impact of HIV infection -- 5. Clinical Manifestations of HIV-associated tuberculosis in adults -- 6. The tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) -- 7. Diagnosis of HIV-associated tuberculosis -- 8. Recent advances in the treatment of latent tuberculosis infection among adults living with HIV -- 9. Treatment of drug-sensitive tuberculosis in persons with HIV -- 10. Drug-resistant TB and HIV -- 11. Co-treatment of tuberculosis and HIV: pharmacologic considerations -- 12. HIV and TB in children -- 13. Neurological TB in HIV | ||
| 520 | |a Globally, HIV-associated tuberculosis is one of the most important causes of infection-related death, accounting for over 300,000 deaths worldwide in 2017. The HIV epidemic has undermined TB control efforts in many countries across the world, as the virus has important modifying effects on the pathogenesis, diagnosis, and treatment of TB. The management of HIV-associated TB is also complicated by rapid clinical progression, immune reconstitution inflammatory syndrome, drug-drug interactions, and shared toxicities. The past two decades have yielded thousands of research publications and review articles on HIV-associated TB. HIV and Tuberculosis: A Formidable Alliance consolidates this massive amount of data into a single resource. With contributions from myriad disciplines, including epidemiology, immunology, public health, and clinical medicine, this book provides well-rounded and thorough coverage that will appeal to researchers and clinicians alike | ||
| 650 | 0 | |a Infectious diseases | |
| 650 | 0 | |a Immunology | |
| 650 | 0 | |a Epidemiology | |
| 650 | 0 | |a Virology | |
| 650 | 2 | |a Tuberculosis |x complications | |
| 650 | 2 | |a HIV Infections |x complications | |
| 650 | 2 | |a AIDS-Related Opportunistic Infections | |
| 700 | 1 | |a Sereti, Irini |e herausgeberin |4 edt | |
| 700 | 1 | |a Bisson, Gregory P. |e herausgeberin |4 edt | |
| 700 | 1 | |a Meintjes, Graeme |e herausgeberin |4 edt | |
| 776 | 1 | |z 9783030291075 | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 978-3-030-29107-5 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-030-29108-2 |m X:SPRINGER |x Resolving-System |z lizenzpflichtig |
| 856 | 4 | 2 | |u https://swbplus.bsz-bw.de/bsz1684967198cov.jpg |m V:DE-576 |m X:SPRINGER |q image/jpeg |v 20191211170344 |3 Cover |
| 912 | |a ZDB-2-SBL |b 2019 | ||
| 912 | |a ZDB-2-SEB | ||
| 912 | |a ZDB-2-SXB |b 2019 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a ISIL_DE-18 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_22_i06404 | ||
| 912 | |a GBV_ILN_65 | ||
| 912 | |a ISIL_DE-3 | ||
| 912 | |a GBV_ILN_100 | ||
| 912 | |a ISIL_DE-Ma9 | ||
| 912 | |a GBV_ILN_101 | ||
| 912 | |a ISIL_DE-Ma14 | ||
| 912 | |a GBV_ILN_120 | ||
| 912 | |a ISIL_DE-715 | ||
| 912 | |a GBV_ILN_130 | ||
| 912 | |a ISIL_DE-700 | ||
| 912 | |a GBV_ILN_285 | ||
| 912 | |a ISIL_DE-517 | ||
| 912 | |a GBV_ILN_381 | ||
| 912 | |a GBV_ILN_2003 | ||
| 912 | |a ISIL_DE-25 | ||
| 912 | |a GBV_ILN_2006 | ||
| 912 | |a ISIL_DE-14 | ||
| 912 | |a GBV_ILN_2014 | ||
| 912 | |a ISIL_DE-90 | ||
| 912 | |a GBV_ILN_2015 | ||
| 912 | |a ISIL_DE-93 | ||
| 912 | |a GBV_ILN_2017 | ||
| 912 | |a ISIL_DE-576 | ||
| 912 | |a GBV_ILN_2064 | ||
| 912 | |a ISIL_DE-953 | ||
| 951 | |a BO | ||
| 953 | |2 045F |a 616.9101 | ||
| 980 | |2 22 |1 01 |x 0018 |b 356350945X |c 00 |f --%%-- |d --%%-- |e s |j --%%-- |h h64 Springer Biomedical |k Campuslizenz Universität Hamburg. - Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y zi06404 |z 11-12-19 | ||
| 980 | |2 65 |1 01 |x 0003 |b 3572752272 |c 03 |f --%%-- |d ebook |e --%%-- |j --%%-- |h OLR-SEB-ZDB-2-SBL |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Die Weitergabe an Dritte sowie systematisches Downloaden sind untersagt. |y k3o |z 05-01-20 | ||
| 980 | |2 100 |1 01 |x 3100 |b 3572667267 |c 00 |f --%%-- |d --%%-- |e s |j --%%-- |c 09 |f --%%-- |d eBook Springer |e --%%-- |j --%%-- |h OLR-SEB |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y z |z 05-01-20 | ||
| 980 | |2 101 |1 01 |x 3101 |b 357268143X |c 00 |f --%%-- |d --%%-- |e s |j --%%-- |c 09 |f --%%-- |d eBook Springer |e --%%-- |j --%%-- |h OLR-SEB |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y z |z 05-01-20 | ||
| 980 | |2 120 |1 01 |x 0715 |b 3572686814 |h OLR-ESP |k Campusweiter Zugriff (Universität Oldenburg). - Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden. |y z |z 05-01-20 | ||
| 980 | |2 120 |1 02 |x 0715 |b 3579470361 |c 00 |f --%%-- |d --%%-- |e g |j --%%-- |h alma |y z |z 23-01-20 | ||
| 980 | |2 130 |1 01 |x 0700 |b 357270300X |h OLR-SEB |k Vervielfältigungen (z. B. Kopien, Downloads) nur für den eigenen wissenschaftlichen Gebrauch. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots |y z |z 05-01-20 | ||
| 980 | |2 285 |1 01 |x 0517 |b 3589306734 |c 00 |f --%%-- |d --%%-- |e s |j --%%-- |h OLR-ESP-SBL |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y z |z 07-02-20 | ||
| 980 | |2 381 |1 01 |x 4381 |b 3572508371 |h OLR-SEB |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots |y z |z 05-01-20 | ||
| 980 | |2 2003 |1 01 |x DE-25 |b 3562966016 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |k Elektronischer Volltext - Universitätslizenz |y l01 |z 10-12-19 | ||
| 980 | |2 2006 |1 01 |x DE-14 |b 3563101094 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 10-12-19 | ||
| 980 | |2 2014 |1 01 |x DE-90 |b 3563101108 |c 00 |f --%%-- |d --%%-- |e --%%-- |j kp |y l01 |z 10-12-19 | ||
| 980 | |2 2014 |1 02 |x DE-90 |b 3563101116 |c 00 |f --%%-- |d --%%-- |e --%%-- |j kp |y l02 |z 10-12-19 | ||
| 980 | |2 2015 |1 01 |x DE-93 |b 3563101124 |c 00 |f --%%-- |d --%%-- |e p |j --%%-- |k Campuslizenz |y l01 |z 10-12-19 | ||
| 980 | |2 2017 |1 01 |x DE-576 |b 3563101132 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |k Besitznachweis BSZ nur für Dateneinspielung, keine echte Lizenz vorhanden |y l01 |z 10-12-19 | ||
| 980 | |2 2064 |1 01 |x DE-953 |b 3562966024 |c 00 |f --%%-- |d eBook Springer |e --%%-- |j n |k Elektronischer Volltext - Campuslizenz |y l01 |z 10-12-19 | ||
| 981 | |2 22 |1 01 |x 0018 |y Volltextzugang |r https://doi.org/10.1007/978-3-030-29108-2 | ||
| 981 | |2 22 |1 01 |x 0018 |y Nur für Angehörige der Universität Hamburg: Volltextzugang von außerhalb des Campus |r http://emedien.sub.uni-hamburg.de/han/SpringerEbooksUKE/doi.org/10.1007/978-3-030-29108-2 | ||
| 981 | |2 65 |1 01 |x 0003 |y Volltextzugang Campus |r https://doi.org/10.1007/978-3-030-29108-2 | ||
| 981 | |2 100 |1 01 |x 3100 |r https://doi.org/10.1007/978-3-030-29108-2 | ||
| 981 | |2 100 |1 01 |x 3100 |y für Uniangehörige: Zugang weltweit |r https://han.med.uni-magdeburg.de/han/SPR-eBook-BiomedicalandLifeScience-einzeln/doi.org/10.1007/978-3-030-29108-2 | ||
| 981 | |2 101 |1 01 |x 3101 |r https://doi.org/10.1007/978-3-030-29108-2 | ||
| 981 | |2 101 |1 01 |x 3101 |y für Uniangehörige: Zugang weltweit |r https://han.med.uni-magdeburg.de/han/SPR-eBook-BiomedicalandLifeScience-einzeln/doi.org/10.1007/978-3-030-29108-2 | ||
| 981 | |2 120 |1 01 |x 0715 |r https://doi.org/10.1007/978-3-030-29108-2 | ||
| 981 | |2 120 |1 02 |x 0715 |r http://49gbv-uob-primo.hosted.exlibrisgroup.com/openurl/49GBV_UOB/UOB_services_page?u.ignore_date_coverage=true&rft.mms_id=991014958746503501 | ||
| 981 | |2 130 |1 01 |x 0700 |r https://doi.org/10.1007/978-3-030-29108-2 | ||
| 981 | |2 285 |1 01 |x 0517 |y E-books (Springer) |r https://doi.org/10.1007/978-3-030-29108-2 | ||
| 981 | |2 381 |1 01 |x 4381 |y Zugriff nur für GEOMAR-Mitarbeiter / Access for GEOMAR employees only |r https://doi.org/10.1007/978-3-030-29108-2 | ||
| 981 | |2 2003 |1 01 |x DE-25 |r https://www.redi-bw.de/start/unifr/EBooks-springer/10.1007/978-3-030-29108-2 | ||
| 981 | |2 2006 |1 01 |x DE-14 |r https://doi.org/10.1007/978-3-030-29108-2 | ||
| 981 | |2 2014 |1 01 |x DE-90 |y Zugang im Netz des KIT |r https://doi.org/10.1007/978-3-030-29108-2 | ||
| 981 | |2 2014 |1 02 |x DE-90 |y Zugang im Netz der HKA |r https://doi.org/10.1007/978-3-030-29108-2 | ||
| 981 | |2 2015 |1 01 |x DE-93 |r https://doi.org/10.1007/978-3-030-29108-2 | ||
| 981 | |2 2064 |1 01 |x DE-953 |r https://doi.org/10.1007/978-3-030-29108-2 | ||
| 983 | |2 120 |1 00 |x DE-715 |8 99 |a ww | ||
| 985 | |2 22 |1 01 |x 0018 |a h64 ebook | ||
| 985 | |2 120 |1 01 |x 0715 |a YH 1694 | ||
| 995 | |2 22 |1 01 |x 0018 |a h64 Springer Biomedical | ||
| 995 | |2 65 |1 01 |x 0003 |a OLR-SEB-ZDB-2-SBL | ||
| 995 | |2 100 |1 01 |x 3100 |a OLR-SEB | ||
| 995 | |2 101 |1 01 |x 3101 |a OLR-SEB | ||
| 995 | |2 120 |1 01 |x 0715 |a OLR-ESP | ||
| 995 | |2 120 |1 02 |x 0715 |a alma | ||
| 995 | |2 130 |1 01 |x 0700 |a OLR-SEB | ||
| 995 | |2 285 |1 01 |x 0517 |a OLR-ESP-SBL | ||
| 995 | |2 381 |1 01 |x 4381 |a OLR-SEB | ||
| 998 | |2 2003 |1 01 |x DE-25 |0 10-12-19 |f 17 | ||